XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options and Restricted Stock Units (Tables)
3 Months Ended
Mar. 31, 2023
Stock Options and Restricted Stock Units  
Schedule of stock option activity

 

 

 

Weighted-Average

 

Number of

 

Weighted - Average

 

Remaining Contractual

Aggregate

    

Options

    

Exercise Price

    

Term (years)

    

Intrinsic Value

Outstanding at January 1, 2023

 

6,690,490

$

3.09

 

  

 

  

Granted*

 

25,000

 

3.31

 

  

 

  

Exercised

 

(148,167)

 

2.31

 

  

 

  

Forfeited/Expired

 

(64,666)

 

6.96

 

  

 

  

Outstanding at March 31, 2023

 

6,502,657

$

3.07

 

6.94

$

35,414,546

 

 

 

 

Exercisable at March 31, 2023

 

4,041,942

$

2.03

5.87

$

26,301,295

 

 

 

 

Vested and Expected to Vest at March 31, 2023

 

6,502,657

$

3.07

 

6.94

$

35,414,546

*On January 23, 2023 25,000 stock options were issued to a non-employee member of the Company’s advisory board. The stock options vest in 12 monthly installments commencing in June 2023.

    

    

    

Weighted-Average 

    

Number of 

Weighted - Average 

Remaining Contractual 

Aggregate 

Options

Exercise Price

Term (years)

Intrinsic Value

Outstanding at January 1, 2022

5,536,896

$

2.66

  

  

Granted*

 

1,479,558

 

5.21

 

  

 

  

Exercised

 

(22,500)

 

1.17

 

  

 

  

Forfeited/Expired

 

(35,400)

 

5.10

 

  

 

  

Outstanding at March 31, 2022

 

6,958,554

$

3.20

 

7.84

$

26,515,544

Exercisable at March 31, 2022

 

3,418,917

$

1.82

 

6.53

$

17,679,562

Vested and Expected to Vest at March 31, 2022

 

6,958,554

$

3.20

 

7.84

$

26,515,544

*Includes 110,000 stock options granted by the Company to a non-employee director of the Company during the three-month period ended March 31, 2022. The stock option fully vests on January 1, 2025.

Weighted-Average

Number of

Weighted - Average

Remaining Contractual

Aggregate

    

Options

    

Exercise Price

    

Term (years)

    

Intrinsic Value

Outstanding at January 1, 2023

 

1,027,500

$

3.46

 

  

 

  

Granted

 

-

 

-

 

  

 

  

Exercised

 

-

 

-

 

  

 

  

Forfeited/Expired

 

(33,500)

 

3.41

 

  

 

  

Outstanding at March 31, 2023

 

994,000

$

3.46

 

9.51

$

5,051,370

Exercisable at March 31, 2023

 

31,250

$

5.20

 

9.29

$

104,500

Vested and Expected to Vest at March 31, 2023

 

994,000

$

3.46

 

9.51

$

5,051,370

Schedule of weighted average assumptions

For the Three Months Ended March 31, 

    

2023

    

2022

Weighted average fair value of options granted

$

1.79

$

3.10

Risk-free interest rate

3.88

%

1.94%-2.33

%

Expected term (years)

3.0

6.0-6.42

Expected volatility factor

79.95

%

62.00

%

Expected dividends

-

-

Schedule of stock-based compensation expense

For the Three Months Ended

March 31, 

    

2023

    

2022

Direct operating costs

$

63

$

52

Selling and administrative expenses

 

899

 

485

Total stock-based compensation

$

962

$

537

Restricted Stock Units  
Stock Options and Restricted Stock Units  
Summary of restricted stock under the company's plan

    

Number of

    

Weighted-Average

Restricted Stock

Grant Date

Units

Fair Value

Unvested at January 1, 2022

 

-

 

$

-

Granted*

 

700,000

5.59

Vested

 

-

 

-

Forfeited/Expired

 

-

 

-

Unvested at March 31, 2022

 

700,000

$

5.59

* 200,000 RSUs were issued under the 2013 Plan and 500,000 RSUs were issued under the 2021 Plan.